Home › Funds › Ratan Capital Management LP › SOLV
Ratan Capital Management LP position in SOLV
SOLVENTUM CORP · Health Care
Ratan Capital Management LP reported holding 20,000 shares of SOLV (SOLVENTUM CORP) in its Q2 2026 13F filing — a position valued at US$1.5M, representing 0.50% of its reported portfolio and ranking #28 among its reported holdings. Ratan Capital Management LP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ratan Capital Management LP's SOLV position evolved
Ratan Capital Management LP first disclosed a stake in SOLV in Q2 2024 at 4,800 shares (US$254K). The position peaked in Q4 2025 at 250,605 shares, worth US$18.3M. Across 9 filings, Ratan Capital Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 20,000 shares valued at US$1.5M. Notable position changes include a 4176% increase in Q3 2025 (shares rose 9% over the following quarter), a 92% trim in Q1 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 4.80K | $253.82K | New |
| Q3 2024 | 4.80K | $253.82K | Hold |
| Q4 2024 | 4.80K | $317.09K | Hold |
| Q1 2025 | 4.80K | $364.99K | Hold |
| Q2 2025 | 4.80K | $530.88K | Hold |
| Q3 2025 | 205.26K | $14.98M | Add |
| Q4 2025 | 250.60K | $18.27M | Add |
| Q1 2026 | 20.00K | $1.31M | Reduce |
| Q2 2026 | 20.00K | $1.54M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SOLV and 13F data
SOLV (SOLVENTUM CORP) is a Health Care company. 45 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.25B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$486.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SOLV
- Independent Franchise Partners LLP 16.17M sh · $1.25B · Q2 2026
- TRIAN FUND MANAGEMENT, L.P. 8.24M sh · $635.47M · Q2 2026
- DAVIS SELECTED ADVISERS 6.31M sh · $486.69M · Q2 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 1.95M sh · $150.07M · Q2 2026
- Madison Avenue Partners, LP 1.74M sh · $134.34M · Q2 2026
- EQUITY INVESTMENT CORP 882.02K sh · $68.05M · Q2 2026
- Ruffer LLP 776.47K sh · $59.84M · Q2 2026
- ANCHOR CAPITAL ADVISORS LLC 582.76K sh · $44.96M · Q2 2026
More on Ratan Capital Management LP
FAQ
How long has Ratan Capital Management LP held SOLV?
Ratan Capital Management LP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Ratan Capital Management LP's current position in SOLV?
As of Q2 2026, Ratan Capital Management LP holds 20.00K shares of SOLV (SOLVENTUM CORP), valued at $1.54M, representing 0.50% of its reported portfolio and ranking #28.
Has Ratan Capital Management LP been buying or selling SOLV?
In the latest 13F filing (Q2 2026), Ratan Capital Management LP held unchanged its position in SOLV. The position peaked in Q4 2025 at 250.60K shares.
Which other funds hold SOLV?
Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.